Outpatient Parenteral Antibiotic Therapy (OPAT) Conference & Workshops

Part of the BSAC OPAT Initiative

NATIONAL OPAT CONFERENCE 2025

A hybrid event to be held on 14 November 2025
ROYAL COLLEGE OF PHYSICIANS, LIVERPOOL & ONLINE

A GLOBAL OVERVIEW OF DRUG DEVELOPMENT AND EFFECTIVE USE THROUGH DIAGNOSTICS, STEWARDSHIP AND SHARED LEARNING

Outpatient parenteral antimicrobial therapy (OPAT) allows for medically stable patients to be discharged (or avoid admission completely) who require a course of intravenous antimicrobial agents. OPAT is a vital scheme that can prevent hospital admissions, reduce a patient’s length of stay in hospital through early discharge, plus reduce the risk of hospital acquired infections.

If you are thinking about setting up, or currently run an OPAT service, the BSAC will be hosting a National OPAT Conference online and in-person at the Royal College of Physicians, Liverpool, on 14 November 2025.

For all queries, please contact Esme Carruthers.

Registration and abstract submission is now open.

Programme

0830
Registration & coffee
0925
Welcome & opening remarks
Andrew Seaton, NHS Greater Glasgow & Clyde and President, BSAC - View Bio

SESSION ONE: OPAT in 2025 - Integrating OPAT in the NHS vision
Chair: Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust
0930
The time is right for OPAT - the question is how?
Devon Elliott, National Antimicrobial Resistance Lead, NHS England - View Bio
1000
Getting AMS right at the primary / secondary care interface?
Andrew Seaton, NHS Greater Glasgow & Clyde - View Bio
1030
pAMS network vision – empowering District General Hospitals
Charlotte Fuller, Leeds Children’s Hospital - View Bio
1100
Q&A

1115
COFFEE BREAK, EXHIBITION & POSTERS

SESSION TWO: Getting the governance right in OPAT?
Chair: Claire Vallance, Queen Elizabeth University Hospital
1140
New Adult & Paediatric Good Practice Recommendations – a brief overview
Ann Noble, NHS Lothian - View Bio
1155
Visualising your data - Initial results from BSAC PPS OPAT survey
Shay Khan, Specialist Infection Pharmacist, Whittington Health NHS Trust - View Bio
1210
Drug Stability - What next?
Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust - View Bio
1225
Q&A

TECHNICAL BREAK - 5 MINUTES

SESSION THREE: SUPPORTED SESSION
1245
Presentation to be confirmed

1310
LUNCH BREAK, EXHBITION & POSTERS

SESSION FOUR: OPAT in Practice
Chair: Ann Noble, NHS Lothian
1350
Mission Possible: Reframing barriers to OPAT self-administration in vulnerable patients
Gianni Acuram, OPAT lead clinical nurse specialist, King's College Hospital - View Bio
1405
OPAT shared care across boundaries
Helena White, Infectious diseases consultant, University Hospitals Leicester - View Bio
1420
10 year experiences of managing OPAT and Dialysis - What have we learnt in implementing the GPR's
Carolyn Hemsley, Consultant in Infectious Diseases & Microbiology, Guy’s and St Thomas’ NHS Foundation Trust - View Bio
1435
Retrospective assessment of OPAT vetting in a large teaching hospital based service
Simon Pybus, NHS Golden Jubilee, Glasgow - View Bio
1450
To be selected from abstracts
1505
Q&A

1520
COFFEE BREAK, EXHIBITION & POSTERS

SESSION FIVE: Evidence & Innovation within OPAT
Chair: Carolyn Hemsley, Consultant in Infectious Diseases & Microbiology, Guy’s and St Thomas’ NHS Foundation Trust
1545
Early use of Rezafungin: a case series at St George's
Tihana Bicanic, City St George’s, University of London & St George’s Hospital - View Bio
1600
Oral antimicrobial therapy for infective endocarditis: real-world experience from a teaching hospital in Scotland
Nikolas Rae, Ninewells Hospital, Dundee
1615
To be selected from abstracts
1630
Review of a formalised palliative care OPAT service in a London teaching hospital
Elena Ferran, Royal Free NHS Foundation Trust
1645
Q&A

1700
Closing remarks & next steps
Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust - View Bio

Registration

Registration is now open for this hybrid conference. Please select if you will attend in-person or virtually as part of the registration process.

Registration fees:

BSAC Members (NHS/not for profit) £80
Non-BSAC Members (NHS/not for profit) £100
Commercial £200
Student £25
Please note, registration is free for nurses, please contact Esme Carruthers to register.

Please use the registration link below to register.

Click here    -  Register >

Abstract Submission

Please submit your abstract(s) using the online submission form for consideration for POSTER presentation at the conference.

All accepted abstracts will be published in JAC-Antimicrobial Resistance

Poster submission deadline: 1700hrs BST on Friday 10 October 2025

Please note our Conditions of Submission:

Abstracts must be submitted by the deadlines stated above. Submissions received after this time may not be considered.
The first author should ideally be the presenting author. The presenting author must register for the conference and can attend either in-person or virtually.
PLEASE NOTE: It is the responsibility of the author(s) to provide printed poster(s) in A0 portrait for abstracts accepted for presentation.
All abstracts are to be submitted using the online submission form. Please use the Supporting documents button to upload your full abstract in a Word file that includes the complete abstract formatted as specified below.
Please do not include figures, tables or references in your abstract (these can be presented in your poster, or slides for an oral presentation, but the abstract should be text only).
By submitting the abstract you confirm, and on behalf of any co-contributors, the following:

You have secured the necessary permissions (and paid any associated fees) to reuse any third-party material included in the abstract.
You grant to JAC-Antimicrobial Resistance/BSAC, and by extension its publisher, Oxford University Press (OUP), the license:
a) to publish the final version of the conference abstract in JAC-Antimicrobial Resistance, and to distribute it and/or to communicate it to the public, either within the Journal, on its own, or with other related material throughout the world, in printed, electronic or any other format or medium whether now known or hereafter devised;
b) to make translations of the abstract and to distribute them to the public; to authorise or grant licenses to third parties to do any of the above;
c) to deposit copies of the abstract in online archives maintained by OUP or by third parties authorised by OUP; and
d) to administer subsidiary rights agreements with third parties for the full period of copyright and all renewals, extensions, revisions and revivals.

Format of Abstracts:
Abstracts should be no longer than 500 words and contain:

a title;
the full list of authors (in the order they should appear on the published abstract);
all author affiliations (including institution, city and country for each);
an initial statement of specific objectives of the study, unless this is given in the title;
a brief statement of methods;
a summary of the results obtained;
specific conclusions.
For example, standard headings are Background (optional), Objectives, Patients and methods (or Methods), Results, and Conclusions.

For any queries regarding abstract submissions, please contact Esme Carruthers.

Lead Author Name
Drag & Drop Files, Choose Files to Upload
Top